168 related articles for article (PubMed ID: 31728810)
21. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
22. Growth factors and pathogenesis.
Islam MS; Greco S; Janjusevic M; Ciavattini A; Giannubilo SR; D'Adderio A; Biagini A; Fiorini R; Castellucci M; Ciarmela P
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():25-36. PubMed ID: 26527305
[TBL] [Abstract][Full Text] [Related]
23. Expression of matricellular proteins in human uterine leiomyomas and normal myometrium.
Bogusiewicz M; Semczuk A; Juszczak M; Langner E; Walczak K; Rzeski W; Tomaszewski J; Rechberger T
Histol Histopathol; 2012 Nov; 27(11):1495-502. PubMed ID: 23018248
[TBL] [Abstract][Full Text] [Related]
24. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
25. Aberrant DNA methylation status in human uterine leiomyoma.
Yamagata Y; Maekawa R; Asada H; Taketani T; Tamura I; Tamura H; Ogane J; Hattori N; Shiota K; Sugino N
Mol Hum Reprod; 2009 Apr; 15(4):259-67. PubMed ID: 19218588
[TBL] [Abstract][Full Text] [Related]
26. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
[TBL] [Abstract][Full Text] [Related]
27. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
28. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
29. Prolactin is Expressed in Uterine Leiomyomas and Promotes Signaling and Fibrosis in Myometrial Cells.
DiMauro A; Seger C; Minor B; Amitrano AM; Okeke I; Taya M; Rackow AR; Kumar D; Kottman RM; Bhagavath B; Hammes SR
Reprod Sci; 2022 Sep; 29(9):2525-2535. PubMed ID: 34724171
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Strissel PL; Swiatek J; Oppelt P; Renner SP; Beckmann MW; Strick R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):42-7. PubMed ID: 17646097
[TBL] [Abstract][Full Text] [Related]
32. Misexpression of wild-type and truncated isoforms of the high-mobility group I proteins HMGI-C and HMGI(Y) in uterine leiomyomas.
Klotzbücher M; Wasserfall A; Fuhrmann U
Am J Pathol; 1999 Nov; 155(5):1535-42. PubMed ID: 10550310
[TBL] [Abstract][Full Text] [Related]
33. PEP-19 overexpression in human uterine leiomyoma.
Kanamori T; Takakura K; Mandai M; Kariya M; Fukuhara K; Kusakari T; Momma C; Shime H; Yagi H; Konishi M; Suzuki A; Matsumura N; Nanbu K; Fujita J; Fujii S
Mol Hum Reprod; 2003 Nov; 9(11):709-17. PubMed ID: 14561813
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
35. The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells.
Mason HR; Lake AC; Wubben JE; Nowak RA; Castellot JJ
Mol Hum Reprod; 2004 Mar; 10(3):181-7. PubMed ID: 14981145
[TBL] [Abstract][Full Text] [Related]
36. Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium.
Sharara FI; Nieman LK
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):814-9. PubMed ID: 7573249
[TBL] [Abstract][Full Text] [Related]
37. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.
Yang Q; Mas A; Diamond MP; Al-Hendy A
Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306
[TBL] [Abstract][Full Text] [Related]
38. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding.
Anania CA; Stewart EA; Quade BJ; Hill JA; Nowak RA
Mol Hum Reprod; 1997 Aug; 3(8):685-91. PubMed ID: 9294852
[TBL] [Abstract][Full Text] [Related]
39. Recently discovered interstitial cells "telocytes" as players in the pathogenesis of uterine leiomyomas.
Varga I; Klein M; Urban L; Danihel L; Polak S; Danihel L
Med Hypotheses; 2018 Jan; 110():64-67. PubMed ID: 29317071
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
